Our Services
​
Strategic Planning and Implementation
Medical Monitoring
Drug Safety
ECG Evaluation and Thorough QT Studies
Program and Project Management
Medical Writing
Therapeutic Areas
SPCI consultants have a wealth of experience across a broad range of disease indications. A partial list of our therapeutic area experience is shown below, representing hundreds of Phase I-IV clinical trials:
​​
-
CNS Disease:
-
ADD
-
Generalized Anxiety Disorder
-
Major Depressive Disorder
-
PTSD
-
Parkinson Disease and PD Psychosis
-
Multiple Sclerosis
-
Amyotrophic Lateral Sclerosis
-
Traumatic Brain Injury
-
-
Device Trials including Autologous Cartilage Implants, Cardiovascular Disease and Epilepsy
-
Diabetes Mellitus
-
Diabetic Foot Ulcer
-
Drug Interaction Studies
-
Epilepsy
-
Fibromyalgia
-
Gene Therapies
-
Gout
-
Headache
-
Hypertension
-
Insomnia
-
Interstitial Cystitis
-
Oncology (Solid tumors: Glioblastoma, Hepatocellular Carcinoma, Prostate, Breast, Lung and Renal cancers; AML, Lymphoma, CLL)
-
Obesity, Anorexia Nervosa and Bulimia
-
Spinal Muscle Atrophy
-
Thorough QT Studies
Marketing Approvals
SPCI consultants were significantly involved in the clinical development program, preparation of the marketing application, or both, for the following FDA-approved drugs and biologics:
Zynrelef®
Spinraza®
Nuplazid®
Zurampic®
Contrave®
Sivextro®
Silenor®
Potiga®
Vectibix®
​